ABSTRACT Polyamine levels were evaluated in human HL-60 promyelocytic leukemia cells after treatment with inducers of terminal differentiation. Differentiation in these cells was determined by increases in the percentage of morphologically mature cells and in lysozyme activity. Treatment of the HL-60 cells with phorbol 12-myristate-13-acetate (PMA), phorbol 12,13-didecanoate or other inducers of terminal differentiation such as dimethylsulfoxide and retinoic acid resulted in increased levels of putrescine. However, no increase in putrescine could be detected after PMA treatment of a HL-60 cell variant that exhibited a decreased susceptibility to PMA-induced terminal differentiation. Similarly, no increase in putrescine was observed with two nontumor-promoters (phorbol 12,13-diacetate and 4-O-methyl-PMA) or with anthralin, a non-phorbol tumor promoter. In addition to enhancing putrescine levels, PMA also increased the amount of spermidine and decreased the amount of spermine. The increase in putrescine and spermidine preceded the expression of the various differentiation markers. Unlike the changes observed in the olyamine levels after PMA treatment, the activities of ornithine and S-adenosylmethionine decarboxylases, which are polyamine biosynthetic enzymes, did not significantly change. a-Methylornithine and a-difluoromethylornithine and methylglyoxal bis(guanylhydrazone), which are inhibitors of the polyamine biosynthetic enzymes, did not affect differentiation in control or PMA-treated cells. Because of these observations, we suggest that the change in polyamine levels involve biochemical pathways other than the known biosynthetic ones.
Phorbol 12-myristate-13-acetate (PMA) and related phorbol diesters, which are plant diterpenes (1) , promote the formation of skin tumors after initiation by a low dose of a carcinogen (2, 3) . In some cultured cell types, these phorbol esters inhibit spontaneous or induced terminal differentiation (4) (5) (6) (7) (8) (9) (10) (11) . In other cells (12) (13) (14) (15) (16) , including the human HL-60 promyelocytic leukemia cells (17) (18) (19) (20) , rather than inhibiting, they can induce such a change. Differentiation in the HL-60 cell line can be characterized by inhibition of cell growth, attachment of cells to the surface of Petri dishes (17) (18) (19) 21) , changes in cell structure (17, 19, 20) , increase in percentage of phagocytizing cells (17) , and stimulation of acid phosphatase and lysozyme activities (19, 20, 22) . In addition to inducing these phenotypic changes, PMA induces the expression of quiescent ribosomal RNA genes in a human-mouse hybrid cell line (23). Thus, the PMA-induced terminal differentiation may result from alterations in the expression of genes associated with the differentiated state.
The physiologically occurring polyamines putrescine, spermidine, and spermine (24, 25) (Fig. 1 ) have been shown to be involved in the regulation of cell growth (24) (25) (26) (27) and in tumor promotion (28) . It was also recently suggested that they may play a role in the control of cell differentiation (29-32; t) . The present studies therefore were undertaken to determine the possible involvement of polyamines in the control of cell growth and differentiation in human HL-60 promyelocytic leukemia cells that can be induced to differentiate by various agents including the tumor-promoting phorbol diesters.
MATERIALS AND METHODS
Chemicals. PMA, phorbol 12,13-diacetate (PDA), phorbol 12,13-didecanoate (PDD), and 4-0-methylphorbol 12- (34) . The cell pellets were lysed for approximately 10 min at 370C in 1 ml of 67 mM potassium phosphate, pH 6.24/0.2% Triton X-100. Cell debris was removed by centrifugation at 500 X g for 5 min. Lysozyme activity was determined by a decrease in turbidity of a cell suspension of Micrococcus lysodeikticus (OD at 450 nm) at 250C, as described in Sigma Bulletin L-6876. The reaction mixture (3 ml) contained 1.3 ml of substrate (0.3 mg of bacteria per ml in phosphate-buffered saline), 0.2 ml of cell lysate, and 1.5 ml of 67 mM potassium phosphate, pH 6.24/0.2% Triton X-100. The growth medium from which the cells had been harvested was also assayed for lysozyme activity. To determine this activity, we used 1.3 ml of substrate, 0.5 ml of growth medium, and 1.2 ml of buffer. The ,ug equivalent of lysozyme activity was estimated by comparing its activity to that of a standard activity curve for purified hen egg white lysozyme (Sigma product L-6876 (Fig. 3A) . The increase in putrescine levels was dose dependent and by 12 hr after treatment with 2 nM PMA, putrescine was increased to 20 nmol/mg of DNA (Fig. 3D) . Spermidine levels were also enhanced from about 60 to 75 nmol/ mg of DNA by 12 hr, after which no further increase was observed. Unlike putrescine and spermidine, no increase in spermine levels could be detected after PMA treatment. On the contrary, in the period between 9 and 24 hr after PMA treatment, spermine decreased from 65 to 50 nmol/mg of DNA (Fig. 3C ). During these experiments, no significant changes in the polyamine levels could be detected in the growth medium.
These results indicate that PMA treatment caused an increase in putrescine and spermidine in the HL-60 cells and this increase could be detected prior to the expression of the differentiation markers such as cell attachment, morphological maturation, and increase in lysozyme activity. Increase in Putrescine Levels by Other Inducers of Terminal Differentiation. Putrescine levels in the HL-60 cells were also determined after treatment with PDD, another tumor-promoting phorbol diester, and with two non-tumor-promoting phorbol diesters, PDA and 4-O-MePMA. In addition, we included in our analysis a non-phorbol diester tumor promoter, anthralin (37) as well as dimethyl sulfoxide and retinoic acid, which are not generally considered to be tumor promoters although the latter has been found to enhance UV-induced skin carcinogenesis (38) . Dimethyl sulfoxide and retinoic acid (33, 39) , unlike anthralin, can induce terminal differentiation in the HL-60 cells. Anthralin at 4 mM inhibited the growth of HL-60 cells but did not produce an increase in the percentage of morphologically mature cells; neither did it increase lysozyme activity, indicating that inhibition of cell growth is not sufficient to induce differentiation in the HL-60 cells. PMA, PDD, dimethyl sulfoxide, and retinoic acid, all of which can induce terminal differentiation in HL-60 cells, yielded putrescine levels that were higher than control (Table 1) The relationship between the ability of four phorbol diesters, anthralin, dimethyl sulfoxide, and retinoic acid to act as inducers of terminal differentiation and their ability to stimulate putrescine levels in the HL-60 cells and the absence of increased putrescine levels in the PMA-resistant cells suggests that the alterations in polyamine levels are associated with the induction of cell differentiation in the HL-60 cells.
Polyamine Biosynthesis Enzyme Activities. To determine whether the increase in putrescine levels was due to a stimulation of polyamine biosynthetic enzymes, we tested ODCase and AdoMetDCase activities in both the control and PMAtreated HL-60 cells. During the 1.5-9 hr after treatment with 0.5 nM PMA, the ODCase activities from the control and treated cells were similar, -1.5 nmol of CO2 per mg of protein per hr. By 24 hr, these activities decreased to about 0.5 nmol of CO2 per mg of protein per hr. These results suggest that the increase in putrescine induced by PMA is not due to a stimulation of ODCase activity. We have also tested F2MeOrn, an irreversible ODCase inhibitor (40) , for its effect on polyamine biosynthesis and cell differentiation in HL-60 cells. F2MeOrn at 1-5 mM was added 2 hr prior to treatment with PMA and was present during a 12-hr period of the PMA treatment for polyamine analysis and a 48-hr period for cell differentiation assessment. F2MeOrn decreased putrescine in the control and PMA-treated HL-60 cells to undetectable levels, decreased spermidine to less than 50% of its normal levels, and inhibited cell growth but did not affect control or PMA-induced cell differentiation. As in the case of F2MeOrn, the reversible ODCase inhibitor a-methylomithine (26, 27, 41) (1, (17) (18) (19) (20) , and other inducers of terminal differentiation in the HL-60 cells such as dimethyl sulfoxide (33) (43, 44) . PMA treatment, which in the HL-60 cells inhibits DNA synthesis (21) and cell growth and induces terminal differentiation (17) (18) (19) (20) , causes an increase in putrescine and spermidine levels and a decrease in the level of spermine without affecting ODCase and AdoMetDCase activities. These results suggest that the increase in putrescine and spermidine levels may involve biochemical pathways other than the known biosynthetic ones (Fig. 1) . Our preliminary studies with labeled putrescine and spermine indicated that the synthesis of polyamines in the HL-60 cells can follow the known route of putrescine to spermine via spermidine as well as the reverse cycle from spermine to spermidine (Fig. 1) . However, no significant conversion of spermidine to putrescine could be detected (unpublished data). Thus, the putrescine increase could occur by another, as yet unknown, pathway. The decrease of spermine levels in the PMA-treated cells, which may result from an increase in the conversion of spermine to spermidine with liberation of an aminoaldehyde and H202 (Fig. 1) (45) , perhaps may be a controlling factor in PMA-induced cell differentiation. It therefore would be of interest to study these products, as well as 5'-methylthioadenosine, the by-product of spermidine and spermine Cell growth, morphological differentiation, and lysozyme activities were determined 2 days after treatment PMA; putrescine was measured after 12 hr of treatment.
biosynthesis (24, 25) , for their effect on cell growth and cell differentiation in the HL-60 cells. Another factor influencing the altered polyamine levels observed after PMA treatment may be changes in polyamine acetylation patterns' (25) .
An interesting possibility is that PMA alters polyamine levels by affecting transglutaminases that can use polyamines as their physiological substrates (46) . These enzymes alter membrane and receptor functions (47, 48) which in turn may change the cells' response to natural inducers of differentiation present in the serum used for the cell-cultures (49, 51) ..Such possibilities may explain why ODCase inhibitors a-methylornithine and F2MeOrn and the AdoMetDCase inhibitor MGBG did not change the differentiation patterns in both control and PMAtreated cells. If, on the other hand, the polyamine changes are simply a consequence of the induced differentiation, the fact remains that changes in their levels precede inhibition of growth, changes in cell appearance, and lysozyme activity. Thus, they may at least serve as early markers of differentiation in HL-60 cells and perhaps other cell types.
This 
